|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-1-6
|
|
pubmed:abstractText |
Estrogen or combined hormone (estrogen-progestin) therapy is highly efficacious for managing the signs and symptoms of urogenital atrophy. A low, effective estrogen dose may enhance patient acceptance and reduce side effects.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0378-5122
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
20
|
|
pubmed:volume |
47
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
47-54
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14706765-Adult,
pubmed-meshheading:14706765-Aged,
pubmed-meshheading:14706765-Aged, 80 and over,
pubmed-meshheading:14706765-Atrophy,
pubmed-meshheading:14706765-Estradiol Congeners,
pubmed-meshheading:14706765-Estrogens,
pubmed-meshheading:14706765-Estrogens, Conjugated (USP),
pubmed-meshheading:14706765-Female,
pubmed-meshheading:14706765-Humans,
pubmed-meshheading:14706765-Hydrogen-Ion Concentration,
pubmed-meshheading:14706765-Middle Aged,
pubmed-meshheading:14706765-Postmenopause,
pubmed-meshheading:14706765-Treatment Outcome,
pubmed-meshheading:14706765-Vagina,
pubmed-meshheading:14706765-Vaginitis
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Low-dose (0.3 mg) synthetic conjugated estrogens A is effective for managing atrophic vaginitis.
|
|
pubmed:affiliation |
Chicago Center for Clinical Research, 515 North State Street, Suite 2700, Chicago, IL 60610, USA. phylissmarx@radiantresearch.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
